Actively hiring
LLM & Generative AI
Biologics & Biosimilars
Artificial Intelligence
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Cambridge Angels, Future Planet Capital
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Registers and programsofficial lists and records that name the company
| Legal entity | Antiverse Ltd | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.

Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody…

Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…

THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…

Synteny harnesses high-throughput data and generative AI to design precision TCR bispecific therapies.

Advanced Antibody Design Services. Macromoltek harnesses the power of computational modeling and artificial intelligence to accelerate and…

Cambridge Angels
Future Planet Capital